This is an Early Exploratory Study to Assess the Tolerability and Safety of GC012F in Patients With Multiple Sclerosis
Clinical trial NCT07303790 · RECRUITING
Trial details
- NCT number
- NCT07303790
- Sponsor
- Daishi Tian
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-09
- Primary completion
- 2027-01-20
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.